Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer.
Schaafsma BE, Verbeek FP, Rietbergen DD, van der Hiel B, van der Vorst JR, Liefers GJ, Frangioni JV, van de Velde CJ, van Leeuwen FW, Vahrmeijer AL. Schaafsma BE, et al. Among authors: van der vorst jr, van de velde cj, van der hiel b, van leeuwen fw. Br J Surg. 2013 Jul;100(8):1037-44. doi: 10.1002/bjs.9159. Epub 2013 May 21. Br J Surg. 2013. PMID: 23696463 Free PMC article.
Blue dye can be safely omitted in most sentinel node procedures for melanoma.
van der Ploeg IM, Madu MF, van der Hage JA, Wouters MW, Klop WM, van der Hiel B, van de Wiel BA, van Akkooi AJ. van der Ploeg IM, et al. Among authors: van der hage ja, van de wiel ba, van akkooi aj, van der hiel b. Melanoma Res. 2016 Oct;26(5):464-8. doi: 10.1097/CMR.0000000000000271. Melanoma Res. 2016. PMID: 27232099
Gamma probe and ultrasound-guided fine needle aspiration cytology of the sentinel node (GULF) trial.
Verver D, Oude Ophuis CMC, Koppert LB, de Monyé C, van Deurzen CHM, Koljenović S, Bruining A, van der Hiel B, Ter Meulen S, van Akkooi ACJ, Verhoef C, Grünhagen DJ. Verver D, et al. Among authors: van akkooi acj, van deurzen chm, van der hiel b. Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1926-1933. doi: 10.1007/s00259-018-4014-3. Epub 2018 Apr 26. Eur J Nucl Med Mol Imaging. 2018. PMID: 29700573 Free PMC article. Clinical Trial.
Three-Dimensional Tumor Margin Demarcation Using the Hybrid Tracer Indocyanine Green-99mTc-Nanocolloid: A Proof-of-Concept Study in Tongue Cancer Patients Scheduled for Sentinel Node Biopsy.
Meershoek P, van den Berg NS, Brouwer OR, Teertstra HJ, Lange CAH, Valdés-Olmos RA, van der Hiel B, Balm AJM, Klop WMC, van Leeuwen FWB. Meershoek P, et al. Among authors: van den berg ns, van leeuwen fwb, van der hiel b. J Nucl Med. 2019 Jun;60(6):764-769. doi: 10.2967/jnumed.118.220202. Epub 2018 Nov 30. J Nucl Med. 2019. PMID: 30504140 Free article.
Technologic (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region.
Berger DMS, van den Berg NS, van der Noort V, van der Hiel B, Valdés Olmos RA, Buckle TA, KleinJan GH, Brouwer OR, Vermeeren L, Karakullukçu B, van den Brekel MWM, van de Wiel BA, Nieweg OE, Balm AJM, van Leeuwen FWB, Klop WMC. Berger DMS, et al. Among authors: van de wiel ba, van den berg ns, van leeuwen fwb, van den brekel mwm, van der hiel b, van der noort v. J Nucl Med. 2021 Oct;62(10):1357-1362. doi: 10.2967/jnumed.120.246819. Epub 2021 Feb 26. J Nucl Med. 2021. PMID: 33637591 Free PMC article.
Intraoperative detection of ganglioneuromas with 123I-MIBG.
van Hulsteijn LT, van der Hiel B, Smit JW, Stokkel MP, Corssmit EP. van Hulsteijn LT, et al. Among authors: van der hiel b. Clin Nucl Med. 2012 Aug;37(8):768-71. doi: 10.1097/RLU.0b013e31825add9b. Clin Nucl Med. 2012. PMID: 22785506
Clinical Prognostic Markers in Stage IIIB Melanoma.
Madu MF, Wouters MW, Klop WM, van der Hiel B, van de Wiel BA, Jóźwiak K, van der Hage JA, van Akkooi AC. Madu MF, et al. Among authors: van de wiel ba, van der hage ja, van akkooi ac, van der hiel b. Ann Surg Oncol. 2016 Dec;23(13):4195-4202. doi: 10.1245/s10434-016-5396-8. Epub 2016 Jul 5. Ann Surg Oncol. 2016. PMID: 27380642
Neoadjuvant Cytoreductive Treatment With BRAF/MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single-arm, Open-label Phase II Trial.
Blankenstein SA, Rohaan MW, Klop WMC, van der Hiel B, van de Wiel BA, Lahaye MJ, Adriaansz S, Sikorska K, van Tinteren H, Sari A, Grijpink-Ongering LG, van Houdt WJ, Wouters MWJM, Blank CU, Wilgenhof S, van Thienen JV, van Akkooi ACJ, Haanen JBAG. Blankenstein SA, et al. Among authors: van der hiel b. Ann Surg. 2021 Aug 1;274(2):383-389. doi: 10.1097/SLA.0000000000004893. Ann Surg. 2021. PMID: 33843797 Clinical Trial.
44 results